approval
saveDEPAKOTE (DIVALPROEX SODIUM) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalDEPAKOTE (DIVALPROEX SODIUM) — FDA approvalMar 31, 2026 · 187d ago
- approvalDEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalMar 31, 2026 · 187d ago
- approvalDEPAKOTE (DIVALPROEX SODIUM) — FDA approvalMar 31, 2026 · 187d ago
- approvalDIVALPROEX SODIUM — FDA approvalJan 29, 2026 · 248d ago
- approvalDIVALPROEX SODIUM — FDA approvalJan 29, 2026 · 248d ago
- approvalDIVALPROEX SODIUM — FDA approvalJan 24, 2026 · 253d ago
- approvalDIVALPROEX SODIUM — FDA approvalJan 24, 2026 · 253d ago
- approvalDIVALPROEX SODIUM — FDA approvalJan 24, 2026 · 253d ago
same company · ±60 days · 6
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalNov 30, 2021
- approvaldivalproex sodium DR: DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalNov 30, 2021
- approvalupadacitinib tartrate ER: RINVOQ (UPADACITINIB) — FDA approvalDec 2, 2021
- approvalupadacitinib tartrate ER: RINVOQ (UPADACITINIB) — FDA approvalDec 14, 2021
- approvalupadacitinib tartrate ER: RINVOQ (UPADACITINIB) — FDA approvalDec 14, 2021
- approvalvenetoclax: VENCLEXTA (VENETOCLAX) — FDA approvalOct 22, 2021
🐶 often sniffed alongside
top 8- tagApproval378 co-mentions · 189 sources
- drugDEPAKOTE334 co-mentions · 190 sources
- drugDEPAKOTE ER334 co-mentions · 190 sources
- drugDIVALPROEX SODIUM190 co-mentions · 190 sources
- drugDivalproex Sodium DR Viatris190 co-mentions · 190 sources
- drugdivalproex sodium ER190 co-mentions · 190 sources
- tagSmall Molecule189 co-mentions · 189 sources
- drugVALPROIC ACID144 co-mentions · 144 sources
comments(0)
5-min edit window · permanent after that